Strength-8

📉 FNBM: SELL Signal (8/10) – Transmission of Annual Report for the Year Ended June 30, 2025

⚡ Flash Summary

First National Bank Modaraba (FNBM) reported a net loss of Rs. 3.9 million for the year ended June 30, 2025, a stark contrast to the previous year’s net profit of Rs. 34.7 million. This decline is attributed to reduced income from short-term deposit placements and ongoing finance costs related to legacy borrowing. Recoveries from non-performing loans (NPLs) slowed, amounting to Rs. 14.75 million compared to Rs. 73.90 million in FY24. Management is actively evaluating strategic options for business revival, including potential balance sheet restructuring. The company remains committed to Shariah compliance and adherence to applicable audit mechanisms.

Signal: SELL 📉
Strength: 8/10
Sentiment: NEGATIVE
Time Horizon: SHORT_TERM

📌 Key Takeaways

  • 📉 FNBM reports a net loss of Rs. 3.9 million in FY25, a significant drop from the Rs. 34.7 million profit in FY24.
  • 💸 Income from short-term placements decreased to Rs. 40.5 million in FY25 from Rs. 49.7 million in FY24 due to SBP policy rate reduction.
  • ⚠️ Accrued finance costs on a short-term loan facility amounted to Rs. 34.2 million in FY25, down from Rs. 49.5 million in FY24.
  • 💰 Recoveries from non-performing portfolio totaled Rs. 14.75 million in FY25, a substantial decrease from Rs. 73.90 million in FY24.
  • ⚖️ Recoveries included Rs. 1.89 million from reversal of doubtful recoveries, Rs. 6.37 million from reversal of suspended income, and Rs. 6.49 million in principal recovered.
  • 💼 Operating expenses were managed at Rs. 16.30 million.
  • 📜 FNBM faces challenges with accumulated losses exceeding 50% of its paid-up fund and a winding-up petition filed by SECP.
  • 🚫 No dividends were declared for the year ended June 30, 2025.
  • 🌱 Management is actively evaluating strategic options under a comprehensive business revival plan.
  • ⚖️ The financial statements have been prepared on the basis of estimated realizable/settlement values of assets and liabilities.
  • ✔️ The company is fully committed to Sharia’h compliance.

🎯 Investment Thesis

SELL. FNBM faces significant financial and legal challenges, with accumulated losses exceeding 50% of its paid-up fund and a winding-up petition filed by SECP. The transition to estimated realizable values signals distress. No dividends were declared, and recovery momentum from NPLs has significantly slowed. There is no price target given the uncertainty.

View Original PDF

Disclaimer: AI-generated analysis. Not financial advice.

Written by: FoxLogica News Analysis

Published on: October 6, 2025

📈 DMC: BUY Signal (8/10) – Financial Results for the Year Ended June 30, 2025

⚡ Flash Summary

D.M. Corporation Limited reported its financial results for the year ended June 30, 2025. The company did not declare any cash dividend, bonus shares, or right shares. The revenue increased from the previous year, resulting in a significant increase in profit after tax. The earnings per share also rose substantially, reflecting improved profitability. The company’s Annual General Meeting will be held on October 28, 2025.

Signal: BUY 📈
Strength: 8/10
Sentiment: POSITIVE
Time Horizon: MEDIUM_TERM

📌 Key Takeaways

  • 💰 No cash dividend was declared for the year ended June 30, 2025.
  • ❌ No bonus shares were issued.
  • 🚫 No right shares were offered.
  • 📈 Revenue increased to PKR 32.48 million from zero in the previous year.
  • 🚀 Profit from operations surged to PKR 48.69 million compared to PKR 18.06 million in 2024.
  • ✨ Profit before tax reached PKR 40.39 million, a significant increase from PKR 14.94 million in the previous year.
  • ✅ Profit after tax soared to PKR 45.30 million, up from PKR 14.85 million in 2024.
  • 💸 Earnings per share (EPS) increased significantly to PKR 14.84 from PKR 4.87 in the previous year.
  • 🗓️ Annual General Meeting to be held on October 28, 2025.
  • 📚 Share transfer books will be closed from October 21, 2025, to October 28, 2025.
  • 🏢 Increase in total equity to PKR 713.22 million from PKR 662.83 million.
  • ⬆️ Increase in Total Assets from PKR 786.32 million to PKR 810.51 million

🎯 Investment Thesis

BUY. D.M. Corporation Limited presents a compelling investment opportunity based on its improved financial performance in the year ended June 30, 2025. The significant increase in revenue, profitability, and EPS indicates a strong turnaround and growth potential. The company’s strategic focus on operational efficiency and market expansion is expected to drive further growth. Price target: PKR 25. Time horizon: Medium Term.

View Original PDF

Disclaimer: AI-generated analysis. Not financial advice.

Written by: FoxLogica News Analysis

Published on: October 6, 2025

📉 DWTM: SELL Signal (8/10) – Transmission of Annual Report for the Year Ended June 30,2025

⚡ Flash Summary

Dewan Textile Mills Limited’s 56th Annual General Meeting announcement reveals a company grappling with significant financial challenges. Operational sales are nil due to a factory shutdown since December 2015. The company faces an adverse opinion from auditors regarding its ability to continue as a going concern, coupled with defaults in restructured liabilities. A restructuring proposal is pending with lenders, with management hopeful for a resolution.

Signal: SELL 📉
Strength: 8/10
Sentiment: NEGATIVE
Time Horizon: SHORT_TERM

📌 Key Takeaways

  • ❌ Operations have been suspended since December 2015 due to industry challenges and working capital constraints.
  • 📉 The company reported a loss after taxation of Rs. 126.36 million for the year ended June 30, 2025.
  • ⚠️ Auditors express an adverse opinion on the going concern assumption.
  • 🏦 Defaults in repayment of restructured liabilities have led to lenders filing execution suits.
  • 🤝 The company is pursuing further restructuring of its liabilities with lenders.
  • 🚫 No provision for markup amounting to Rs. 428.480 million was made in the financial statements.
  • 🏛️ Certain lenders continue to pursue suits in the High Court for recovery of liabilities amounting to Rs. 419.065 million.
  • 🌱 GDP is expected to grow by 3.6% in FY 202526, according to IMF estimates.
  • 🌪️ Devastating monsoon floods in mid-2026 severely disrupted agricultural output and supply chains.
  • 📉 The textile sector was particularly impacted by losses in the local cotton crop.
  • ⚖️ The company is involved in legal disputes regarding Gas Infrastructure Development Cess Ordinance, 2014.
  • 👨‍💼 Six Board meetings were held during the financial year ended June 30, 2025.
  • 🔒 The share transfer books will remain closed from October 20, 2025, to October 27, 2025.

🎯 Investment Thesis

Given the very high levels of financial and operational risk, a SELL recommendation is warranted. There is no clear path to profitability or long-term sustainability, and investors should avoid this stock until significant and material improvements are made.

View Original PDF

Disclaimer: AI-generated analysis. Not financial advice.

Written by: FoxLogica News Analysis

Published on: October 6, 2025

📉 DSFL: SELL Signal (8/10) – Transmission of Annual Report for the Year Ended June 30,2025

⚡ Flash Summary

Dewan Salman Fibre Limited’s (DSFL) Annual Report for the year ended June 30, 2025, reveals a challenging financial landscape marked by continued operational closure and significant accumulated losses. The company’s turnover remained nil due to the cessation of manufacturing activities since December 2008. While management is actively pursuing debt restructuring with financial institutions, an adverse opinion has been issued by the auditors regarding the use of the going concern assumption, adding further uncertainty. The report highlights the Company’s endeavors to navigate these difficulties, including efforts to reduce costs and manage feedstock price changes.

Signal: SELL 📉
Strength: 8/10
Sentiment: NEGATIVE
Time Horizon: SHORT_TERM

📌 Key Takeaways

  • ❌ DSFL reported zero revenue for the year ended June 30, 2025.
  • 📉 The company experienced a Gross Loss of PKR 283.045 million.
  • 😓 Operating Loss widened to PKR 345.904 million.
  • ⛔ Auditors issued an adverse opinion due to concerns about the ‘going concern’ assumption.
  • ⚠️ Financial statements preparation is questionable.
  • 🔍 Trade debts are stagnant, raising concerns about recovery.
  • 📉 Loss per share stood at (PKR 1.04).
  • 🚫 No dividend declared due to adverse financial conditions.
  • 🏢 Company’s operations have been closed since December 2008.
  • 🤝 Debt restructuring proposals are ongoing with financial institutions.
  • 🌍 PSF market faces significant competition from international players.
  • 🇵🇰 The company is exposed to Pak Rupee depreciation risk against the US Dollar.
  • 🚫 The company is lacking the Non-availability of banking lines.

🎯 Investment Thesis

Due to the adverse opinion from auditors, continued operational closure, increasing losses, significant debt and the inherent risks, a SELL recommendation is warranted. There is no reason to expect a turnaround, considering existing challenges and auditors’ concerns. A price target is based on potential asset liquidation value, though highly uncertain. Any potential investor should avoid this security, as per the current situation and report.

View Original PDF

Disclaimer: AI-generated analysis. Not financial advice.

Written by: FoxLogica News Analysis

Published on: October 6, 2025

📉 DWAE: SELL Signal (8/10) – Transmission of Annual Report for the Year Ended June 30,2025

⚡ Flash Summary

Dewan Automotive Engineering Limited’s annual report for the year ended June 30, 2025, reveals a challenging financial situation. The company experienced negative gross and operating profits, alongside a net loss after tax of PKR 51.943 million. The auditor’s report was qualified due to concerns about the company’s ability to continue as a going concern. The company is facing severe working capital constraints and has accumulated significant losses, resulting in a net capital deficiency of PKR 1,576.553 million. Despite these challenges, the management is actively seeking financing to resume normal manufacturing operations.

Signal: SELL 📉
Strength: 8/10
Sentiment: NEGATIVE
Time Horizon: SHORT_TERM

📌 Key Takeaways

  • 📉 Net loss after tax: PKR (51.943) million in 2025 vs PKR (67.912) million in 2024.
  • 📉 Gross loss: PKR (13.249) million in 2025 vs PKR (13.933) million in 2024.
  • 📉 Operating loss: PKR (21.053) million in 2025 vs PKR (16.752) million in 2024.
  • ⚠️ Auditors qualified the report: Due to concerns about going concern.
  • ❗ Accumulated losses: Increased to PKR (2,020.547) million.
  • ❗ Net capital deficiency: PKR (1,576.553) million.
  • ❌ No dividend recommended: Due to losses.
  • ✅ Management is actively seeking financing: To resolve working capital constraints.
  • 📈 Automotive industry in Pakistan: Recovering with a 43% increase in auto sales.
  • ⚖️ Legal compliance: Compliant with corporate governance provisions.
  • 🧑‍💼 Limited workforce: Only two male employees during the year.
  • 🔍 Key risks: Depreciation of PKR vs USD and lack of working capital.
  • 🏢 Main activities: Manufacturing, assembling, and selling vehicles.
  • 🔒 The company’s operations are closed: Due to working capital constraints.

🎯 Investment Thesis

Due to severe financial distress, ongoing losses, auditor qualifications, and high risks, a SELL recommendation is warranted. The company’s ability to continue as a going concern is uncertain. Any price target is highly speculative given the lack of financial stability. Time horizon: Immediate.

View Original PDF

Disclaimer: AI-generated analysis. Not financial advice.

Written by: FoxLogica News Analysis

Published on: October 6, 2025

📈 SHFA: BUY Signal (8/10) – Transmission of Annual Report for the Year Ended June 30, 2025

⚡ Flash Summary

Shifa International Hospitals Ltd. reported strong financial results for the year ended June 30, 2025. Revenue increased by 18.7% to Rs. 27.97 billion, while net profit surged by 71.0% to Rs. 2.33 billion. The company declared a final cash dividend of Rs. 5 per share, a 50% payout. Shifa is strategically expanding with a new national hospital in Faisalabad and a planned acquisition of Shifa Medical Center Islamabad, demonstrating a commitment to growth and quality healthcare across Pakistan. The firm also stands firm on its dedication to ethical labor practices and environmentally conscious strategies.

Signal: BUY 📈
Strength: 8/10
Sentiment: POSITIVE
Time Horizon: MEDIUM_TERM

📌 Key Takeaways

  • 🚀 Revenue jumped 18.7% to Rs. 27.97 billion.
  • 💰 Net profit soared 71.0% to Rs. 2.33 billion.
  • 📈 Earnings per share surged 71.0% to Rs. 36.84.
  • dividend announced per share (50% payout).
  • 🏥 Strategic expansion continues with the new Shifa National Hospital Faisalabad.
  • 🤝 Acquisition of Shifa Medical Center Islamabad planned to strengthen footprint.
  • 🌱 Strong commitment to digitization of healthcare services to improve efficiency.
  • ⚖️ Debt-to-equity ratio remains healthy at 11:89.
  • Exceeds contribution to the national exchequer, 4,571 million
  • 🤝 Partnered up with national clusters and international forums to improve medical quality
  • 🌱 Commitment to environmental stewardship through renewable energy and waste reduction programs.
  • 💸 A high percentage 90.90% of the directors completed the Directors Training Program (DTP)

🎯 Investment Thesis

Shifa International Hospitals presents a compelling BUY opportunity based on its strong financial performance, strategic expansion initiatives, commitment to digitalization, and healthy balance sheet. The company’s commitment to ethical labor practices and environmental stewardship further enhance its long-term sustainability. Target a P/E of 15, leading to a price target = 15*36.84 = 552.6 with a medium term time frame.

View Original PDF

Disclaimer: AI-generated analysis. Not financial advice.

Written by: FoxLogica News Analysis

Published on: October 6, 2025

📈 SHFA: BUY Signal (8/10) – Transmission of Annual Report for the Year Ended June 30, 2025

⚡ Flash Summary

Shifa International Hospitals Ltd. reported strong financial results for the year ended June 30, 2025. Revenue increased by 18.7% to Rs. 27.97 billion, while net profit surged by 71.0% to Rs. 2.33 billion. The company declared a final cash dividend of Rs. 5 per share, a 50% payout. Shifa is strategically expanding with a new national hospital in Faisalabad and a planned acquisition of Shifa Medical Center Islamabad, demonstrating a commitment to growth and quality healthcare across Pakistan. The firm also stands firm on its dedication to ethical labor practices and environmentally conscious strategies.

Signal: BUY 📈
Strength: 8/10
Sentiment: POSITIVE
Time Horizon: MEDIUM_TERM

📌 Key Takeaways

  • 🚀 Revenue jumped 18.7% to Rs. 27.97 billion.
  • 💰 Net profit soared 71.0% to Rs. 2.33 billion.
  • 📈 Earnings per share surged 71.0% to Rs. 36.84.
  • dividend announced per share (50% payout).
  • 🏥 Strategic expansion continues with the new Shifa National Hospital Faisalabad.
  • 🤝 Acquisition of Shifa Medical Center Islamabad planned to strengthen footprint.
  • 🌱 Strong commitment to digitization of healthcare services to improve efficiency.
  • ⚖️ Debt-to-equity ratio remains healthy at 11:89.
  • Exceeds contribution to the national exchequer, 4,571 million
  • 🤝 Partnered up with national clusters and international forums to improve medical quality
  • 🌱 Commitment to environmental stewardship through renewable energy and waste reduction programs.
  • 💸 A high percentage 90.90% of the directors completed the Directors Training Program (DTP)

🎯 Investment Thesis

Shifa International Hospitals presents a compelling BUY opportunity based on its strong financial performance, strategic expansion initiatives, commitment to digitalization, and healthy balance sheet. The company’s commitment to ethical labor practices and environmental stewardship further enhance its long-term sustainability. Target a P/E of 15, leading to a price target = 15*36.84 = 552.6 with a medium term time frame.

View Original PDF

Disclaimer: AI-generated analysis. Not financial advice.

Written by: FoxLogica News Analysis

Published on: October 6, 2025

📉 NCPL: SELL Signal (8/10) – TRANSMISSION OF ANNUAL REPORT FOR THE YEAR ENDED JUNE 30, 2025

⚡ Flash Summary

Nishat Chunian Power Limited (NCPL) reported a significant decline in financial performance for the year ended June 30, 2025. Revenue plummeted to PKR 5.57 billion, compared to PKR 15.22 billion in the previous year, primarily due to reduced capacity factor. The company incurred a loss after tax of PKR 3.38 billion, a stark contrast to the net profit of PKR 4.91 billion in 2024. This translates to a loss per share of PKR 9.19, a considerable deviation from the earnings per share of PKR 13.37 in the prior period. The adverse financial results were influenced by lower generation demand, reduced capacity tariff components, and the impact of an amendment agreement (‘AA’).

Signal: SELL 📉
Strength: 8/10
Sentiment: NEGATIVE
Time Horizon: LONG_TERM

📌 Key Takeaways

  • 📉 Revenue decreased significantly by 63.4% year-over-year, from PKR 15.22 billion to PKR 5.57 billion.
  • ❌ The company recorded a loss after tax of PKR 3.38 billion in 2025, contrasting with a profit of PKR 4.91 billion in 2024.
  • 📉 Loss per share was PKR 9.19 in 2025 compared to earnings per share of PKR 13.37 in 2024.
  • 🏭 Electricity dispatch to Power Purchaser significantly reduced to 57,209 MWH from 240,447 MWH.
  • ⚡️ Plant capacity factor declined to 3.34% from 13.99%.
  • ✅ Availability factor remained high at 99.74% compared to 93.77%.
  • 📜 AA encompasses significant financial impacts approved by the Board of Directors on December 4, 2024.
  • Hybrid Take-and-Pay model implemented from November 1, 2024.
  • 🤝 Full and final settlement of past dues and claims by Power Purchaser improved liquidity position.
  • 💰 Receivables from Power Purchaser reduced to PKR 1,464.17 million from PKR 13,170.21 million.
  • 🚫 Overdue receivables decreased to PKR 1,052.83 million from PKR 10,170.06 million.
  • 💵 Two interim dividends at 50% and 20% respectively have been declared and distributed.
  • 💰 An overhauling reserve of PKR 5,509 million created.

🎯 Investment Thesis

Given the significant decline in financial performance, including a substantial loss, reduced revenue, and the negative impact of the amendment agreement, a SELL recommendation is warranted. The company needs to demonstrate a sustainable recovery in operational performance and profitability before considering an investment. A price target cannot be determined without more information. The time horizon is long-term, pending evidence of a turnaround.

View Original PDF

Disclaimer: AI-generated analysis. Not financial advice.

Written by: FoxLogica News Analysis

Published on: October 6, 2025

📉 GATI: SELL Signal (8/10) – Financial Results for the Year Ended June 30, 2025

⚡ Flash Summary

Gatron Industries reported a challenging year, with a significant decrease in sales and a substantial loss for the year ended June 30, 2025. The company’s revenue declined by approximately 22.6% compared to the previous year, leading to a notable operating loss. Increased finance costs further exacerbated the financial strain. The company reported a loss per share of (18.13) Rupees, a stark contrast to the (2.36) Rupees loss per share in the prior year. Despite the losses, the board did not recommend any cash dividend, bonus shares, or right shares.

Signal: SELL 📉
Strength: 8/10
Sentiment: NEGATIVE
Time Horizon: SHORT_TERM

📌 Key Takeaways

  • 📉 Sales plummeted to PKR 26,328.04 million, a 22.6% decrease from PKR 34,013.58 million in 2024.
  • ⚠️ The company swung from an operating profit of PKR 1,392.50 million in 2024 to an operating loss of PKR (101.45) million in 2025.
  • 💰 Finance costs increased to PKR 1,539.27 million, compared to PKR 1,494.59 million in the previous year.
  • ❌ Loss before levies and income tax amounted to PKR (1,640.72) million, a significant downturn from a loss of PKR (93.55) million in 2024.
  • 🧾 The company reported a loss for the year of PKR (1,971.12) million, sharply down from a loss of PKR (204.36) million in 2024.
  • 📉 Loss per share (basic and diluted) was PKR (18.13), a considerable decline from PKR (2.36) in the previous year.
  • 🚫 No cash dividend was recommended for the year ended June 30, 2025.
  • 🚫 No bonus shares were recommended for the year ended June 30, 2025.
  • 🚫 No right shares were recommended for the year ended June 30, 2025.
  • 🏢 Total assets decreased slightly from PKR 34,588.89 million to PKR 34,236.88 million.
  • 📉 Equity decreased from PKR 13,287.16 million to PKR 11,372.59 million.
  • ⬆️ Long-term financing decreased from PKR 8,507.13 million to PKR 7,628.31 million.

🎯 Investment Thesis

Given the significant decline in financial performance, mounting losses, and negative valuation implications, a SELL recommendation is warranted. The company’s ability to recover in the short to medium term is uncertain. Therefore, a price target cannot be reliably established, but significant downside risk exists. Time horizon is SHORT_TERM as the risks are immediate and substantial.

View Original PDF

Disclaimer: AI-generated analysis. Not financial advice.

Written by: FoxLogica News Analysis

Published on: October 6, 2025

📈 MACTER: BUY Signal (8/10) – Transmission of Annual Report for the year ended June 30, 2025

⚡ Flash Summary

Macter International Limited’s Annual Report for the year ended June 30, 2025, reveals a company experiencing robust growth and profitability. The company reported a 32% increase in net turnover compared to the previous year. This growth was driven primarily by increased unit sales and new product launches, with exports growing by 163%. The company has recommended a final cash dividend of 20%, equivalent to Rs. 2.00 per share, in addition to an interim cash dividend of Rs. 1.80 per share.

Signal: BUY 📈
Strength: 8/10
Sentiment: POSITIVE
Time Horizon: MEDIUM_TERM

📌 Key Takeaways

  • 📈 Net turnover increased by 32% to Rs. 9,914 million, driven by unit sales and new products.
  • 🌍 Export growth reached 163%, reflecting a strategic push for international expansion.
  • 💰 A final cash dividend of 20% (Rs. 2.00 per share) was recommended, plus an interim dividend of 18% (Rs. 1.80 per share).
  • 🌱 Gross margins improved by 2.7% due to a better sales mix and export business.
  • 💼 Operating profit rose by 73% to Rs. 1,234 million, attributed to sales and efficiency.
  • 💸 Finance costs increased marginally by 2% to Rs. 102 million.
  • 📊 Profit before tax grew by 85% to Rs. 1,132 million.
  • ✅ Profit after tax increased by 73% to Rs. 738 million.
  • 🚧 Capital expenditure of Rs. 870 million was made for new equipment and facility upgrades.
  • ⭐ Earnings per share (EPS) increased from Rs. 9.32 to Rs. 16.10.
  • ☀️ Installed a 378 kW solar system to reduce carbon footprint; planning an additional 140 kW.
  • 🏆 Received a credit rating of A/A-1 from VIS Credit Rating Company, with a ‘Stable’ outlook.
  • 🤝 Contributed Rs. 1,079 million to the National Exchequer through taxes and duties.
  • 🛡️ Identified business risks including cost inflation, rupee devaluation, and regulatory requirements.

🎯 Investment Thesis

Macter International Limited is a BUY. Strong revenue growth and increased profitability, alongside the potential for growth with new products and export strategy. A target price of Rs. 650, based on 40x FY25 EPS, reflecting growth potential and dividend yield.

View Original PDF

Disclaimer: AI-generated analysis. Not financial advice.

Written by: FoxLogica News Analysis

Published on: October 3, 2025

+ More